Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin enacarbil response in dopamine-exposed versus dopamine-naive restless legs syndrome patients
2014-005111-16Phase 4Completed
- Sponsor
- Instituto de Investigaciones del Sueño
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gabapentin in restless legs syndrome (RLS) (2 arms), sponsored by Instituto de Investigaciones del Sueño. Primary endpoint: IRLS response comparison. Started Jan 2015; status: completed.
02
Drugs
gabapentin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2014-005111-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005111-16.